Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To demonstrate the statistical non inferiority of the combination of latanoprost and timolol given in the evening time once a day vs the combination of dorzamalide and timolol twice a day based on intraocular pressure measurements at 8 AM, 12 noon & 4 PM during a 12 week treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Xalacom | Drug | |||
| Cosopt | Drug |
| Measure | Description | Time Frame |
|---|---|---|
| The mean IOP measurements obtained in the study eye at each time point |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Pfizer CT.gov Call Center | Pfizer | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Pfizer Investigational Site | Caen | 14033 | France | |||
| Pfizer Investigational Site |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Clermont-Ferrand |
| 63003 |
| France |
| Pfizer Investigational Site | Lyon | 69437 | France |
| Pfizer Investigational Site | Marseille | 13385 | France |
| Pfizer Investigational Site | Saint-Herblain | 44800 | France |
| Pfizer Investigational Site | Darmstadt | 64283 | Germany |
| Pfizer Investigational Site | Darmstadt | 64297 | Germany |
| Pfizer Investigational Site | Landau / Pfalz | 76829 | Germany |
| Pfizer Investigational Site | Regenstauf | 93128 | Germany |
| Pfizer Investigational Site | Schorndorf | 73614 | Germany |
| Pfizer Investigational Site | Starnberg | 82319 | Germany |
| Pfizer Investigational Site | Heraklion | Crete | 71110 | Greece |
| Pfizer Investigational Site | Thessaloniki | Macedonia | 546 36 | Greece |
| Pfizer Investigational Site | Alexandroupoli | 68100 | Greece |
| Pfizer Investigational Site | Larissa | 41110 | Greece |
| Pfizer Investigational Site | Chieti | 66013 | Italy |
| Pfizer Investigational Site | Foggia | 71100 | Italy |
| Pfizer Investigational Site | Genova | 16132 | Italy |
| Pfizer Investigational Site | Milan | 20132 | Italy |
| Pfizer Investigational Site | Monza (MI) | 20052 | Italy |
| Pfizer Investigational Site | Pisa | 56126 | Italy |
| Pfizer Investigational Site | örebro | 703 61 | Sweden |
| Pfizer Investigational Site | Malmö | 205 02 | Sweden |
| Pfizer Investigational Site | Mölndal | 431 80 | Sweden |
| Pfizer Investigational Site | Sundsvall | 851 86 | Sweden |
| ID | Term |
|---|---|
| D005902 | Glaucoma, Open-Angle |
| D009798 | Ocular Hypertension |
| ID | Term |
|---|---|
| D005901 | Glaucoma |
| D005128 | Eye Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| C571753 | Xalacom |
| C479140 | dorzolamide-timolol combination |
Not provided
Not provided
Not provided